drugset / Trial / NCT02584244
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and esophageal cancers (adenocarcinoma) using the LUM Imaging System.
Timeline
- Start
- 2016-08-04
- Primary completion
- 2026-12
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PEGULICIANINE ACETATE | Diagnostic / imaging agent | 0.5 mg/kg | Intravenous |
| Subject | PEGULICIANINE ACETATE | Diagnostic / imaging agent | 1 mg/kg | Intravenous |
| Subject | PEGULICIANINE ACETATE | Diagnostic / imaging agent | 1.5 mg/kg | Intravenous |